Skip to search formSkip to main contentSkip to account menu

Vitamin K Antagonist [EPC]

Known as: Vitamin K Antagonist 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Background: Both antiplatelets and anticoagulants are necessary in the management of acute coronary syndrome (ACS), although the… 
2018
2018
Background and Purpose— Acute ischemic strokes under vitamin K antagonist (VKA) treatment are not uncommon, but intravenous… 
2018
2018
Background: Vitamin K antagonist (VKA)–associated intracerebral hemorrhages (ICHs) are more likely to expand and are associated… 
2018
2018
Abstract Current guidelines recommend as treatment option in patients on oral anticoagulation (OAC) undergoing percutaneous… 
2017
2017
Abstract Since several trials have demonstrated that low-molecular-weight-heparin (LMWH) is superior to vitamin K antagonist (VKA… 
2013
2013
Vitamin K antagonist (VKA) frequently fails to prevent cerebral infarction, with 30% of VKA-treated patients experiencing… 
Review
2009
Review
2009
Based on their mode of action, it is reasonable to expect that the combination therapy of aspirin and a vitamin K antagonist (VKA…